Back to top

PHAR Maintained by Canaccord Genuity -- Price Target Raised to $38

PHAR Maintained by Canaccord Genuity -- Price Target Raised to $38

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Pharming Group N.V. Sponsored ADR (PHAR)